Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy

Clicks: 474
ID: 114298
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Arctigenin is the active content of arctium lappa that present anti-cancer abilities in various carcinomas. However, its role and underlying mechanism in drug-resistant colorectal cancer cells has not been addressed. The present study used SW480 and SW620 to established cisplatin-resistant colorecta …
Reference Key
y2019biochemicalarctigenin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wang Y;Lina L;Xu L;Yang Z;Qian Z;Zhou J;Suoni L;;
Journal Biochemical and biophysical research communications
Year 2019
DOI
DOI not found
URL
https://www.pubmed.gov/31564411/
Keywords
Tumor National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine cell line drug resistance antineoplastic agents / administration & dosage apoptosis doxorubicin / administration & dosage multiple* cell proliferation pmid:31564411 doi:10.1016/j.bbrc.2019.09.086 yuzhen wang li lina li suoni atp binding cassette transporter subfamily b / metabolism autophagy / drug effects* caspase 3 / metabolism caspase 9 / metabolism cisplatin / administration & dosage* colorectal neoplasms / drug therapy* neoplasm* furans / administration & dosage* inhibitory concentration 50 lignans / administration & dosage* oxaliplatin / administration & dosage paclitaxel / administration & dosage up-regulation

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.